Drug industry opposed to incentive program for cheaper drugs.

Published: 2001-11-08 07:00:00

Updated: 2001-11-08 07:00:00

The KPMA made it clear on Nov. 2, that the Association definitely opposed the government's incentive program for cheaper generic drugs to be more consumed at the medical institutes and the drug price reduction plans through the open public tenders as one of the government NHI financial stabilizat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK